SMIadviser.org will not be accessible after 11:59pm ET on July 8, 2024. Thank you for your support over the past six years!

An APA and SAMHSA Initiative

Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Person-First Language
Our Tools
SMI Adviser App My Mental Health Crisis Plan Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Calendar
Contact

Search for:

∕
Knowledge Base (Clinicians)
∕
Psychopharmacology

Tag: Psychopharmacology

Knowledge Base (Clinicians)

185 result(s) found.

Are there any reliable techniques to assess antipsychotic medication adherence?
Using Antidepressants in Pregnancy
Persistent psychotic symptoms in schizophrenia
Management of tardive movement disorders
Cannabis Use and Psychosis in People with Schizophrenia
Salivation side effect of clozapine (sialorrhea)
Antipsychotic Medication Continuation After Improvement in Schizophrenia
Sedation side effect of clozapine
Myocarditis side effect of clozapine
Constipation side effect of clozapine
How do I interpret clozapine or norclozapine blood, serum or plasma levels; What do these mean?
Clozapine blood count monitoring
Seizure side effect of clozapine
When to use clozapine
Orthostatic hypotension due to clozapine
Tachycardia side effect of clozapine
How does one dose or titrate clozapine dosage when starting on this medication?
Is weight gain a problem with clozapine, and what can be done?
What are some strategies for reducing the adverse effects of antipsychotic medications for people with SMI?
What did we learn from the STAR*D study?
What are the pros and cons of taking a long acting injectable antipsychotic medication?
What side effects might be expected after starting an antidepressant medication for the first time?
Does smoking cigarettes interfere with how well medication for schizophrenia works?
How does clozapine work and how is it different from other medications?
Why is clozapine not the first medication chosen to treat schizophrenia for everyone?
What is the difference between the older and newer antipsychotic medications?
How much exercise should people with SMI get per week?
What is the best antidepressant?
Are chatbots useful for serious mental illnesses?
What is clozapine REMS?
Guidance on Strategies to Promote Best Practice in Antipsychotic Prescribing for Children and Adolescents
Do peer support specialists encourage the people they serve in taking medications?
How long should a person take medication for their mental illness before changing the dosage or the type of medication being used?
Can a primary care provider or family practitioner prescribe psychotropic medications?
Is a person ever able to stop taking medications to treat their serious mental illness?
Why are many of the medications used to treat schizophrenia today the same ones that were used 15-30 years ago?
Practice Guidelines for the Psychiatric Evaluation of Adults, Third Edition
Are there smoking cessation treatments that are effective in patients with serious mental illness (SMI)?
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statement
Is it possible to manage symptoms of bipolar disorder without medications–for example, if diet and sleep are in good control?
Persistent Depression and Anxiety in the United States: Prevalence and Quality of Care
Can the medications used to treat serious mental illness (antipsychotics and antidepressants) be addicting?
How often should a full medical workup be done on a person with serious mental illness who is being treated with medications?
What are the challenges of patients accepting medication assisted treatment (MAT) for their opiate use disorder?
Anticonvulsants – Medication Fact Sheets
Mood Stabilizers – Medication Fact Sheets
Antidepressants – Medication Fact Sheets
Second-Generation (atypical) Antipsychotics – Medication Fact Sheets
First-Generation (typical) Antipsychotics – Medication Fact Sheets
Vision side effects of clozapine
Is weight gain or obesity a side effect of antipsychotic medications, and what can be done?
What about ketamine for depression or suicidal ideation?
Perinatal Psychiatry
Medication-Assisted Treatment (MAT) in the Criminal Justice System: Brief Guidance to the States
What are available practice guidelines for substance abuse disorder?
What can I do if it is difficult or risky to start a patient on clozapine? Should patients be started on clozapine in the hospital?
Should I be concerned if eosinophils are low or high with clozapine or there is eosinophilia?
What about anemia in people with serious mental illness, and should I be concerned about ordering blood tests?
What are the issues regarding families and caregivers supporting clozapine treatment?
Are there any contraindications or reasons a patient cannot be considered for clozapine? Can a patient with myocarditis or severe neutropenia be rechallenged and take clozapine again?
What is Benign Ethnic Neutropenia and does it relate to low clozapine white counts?
What should be done if the clozapine treatment of a patient is interrupted, or they do not take their clozapine for a few days or longer?
What can clinicians do when individuals have either a partial or no response to clozapine?
What should primary care providers know how to do if they are working in mental health setting?
Is there a healthcare model that can treat medical problems, mental health conditions and substance use disorders at the same time and place?
How does opioid use disorder increase the risk of contracting Hepatitis C and HIV?
Is it possible to receive primary care inside an opiate treatment program?
How do you optimize the clinical management of persons opioid use disorders (OUD) and co-occurring psychiatric disorders who are actively using opioids and are experiencing significant pain?
How do primary care providers and mental health experts feel about opioid and benzodiazepines co-prescribing?
How are Opioid Use Disorders (OUD) related to non-OUD psychiatric disorders?
What are best practices for managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder and what are the risks associated with it?
Is there anything I should know about smoking, tobacco or nicotine and clozapine?
What are approaches to treatment-resistant depression in patients with bipolar disorder?
Can antipsychotic medications cause neutropenia or agranulocytosis as a side effect?
Should I be concerned about Electroconvulsive Therapy (ECT) in the context of an intracranial mass or lesion?
What metabolic monitoring is appropriate when patients are taking antipsychotic medication? Are there any labs or vital signs to monitor?
Considering the Role of Antipsychotic Medications in My Recovery Plan
Comparative Effectiveness Review Number 215: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
What is the evidence regarding combining multiple antipsychotic medications?
What is known about research on antipsychotic medications and clozapine for schizophrenia in children and adolescents?
What should I consider with an older patient who develops new onset tardive dyskinesia while taking antipsychotic medication?
What are the issues regarding starting clozapine in a patient with structural heart disease, such as cardiomyopathy or cardiac valve disease?
What metabolic monitoring is appropriate when patients are taking clozapine? Should we monitor weight, labs or vital signs?
What drug-drug medication interactions are important when starting or prescribing clozapine?
How does the collaborative care model improve treatment access for people with substance use disorders?
If patients with opioid use disorders are detoxified successfully, why should they take medications rather than remaining “completely abstinent”?
How should doctors and their patients decide on the most appropriate pharmacological treatment with opioid use disorder?
What are the implications of the SAMHSA final rule to increase the Buprenorphine patient limit to 275?
How can psychosocial interventions contribute to improving medication assisted treatment outcomes in patients with SUD?
What are the office procedures that should be followed when prescribing buprenorphine?
How can communities address the barriers for potential outpatient buprenorphine prescribers in order to encourage them to treat patients with opioid use disorder?
What treatments are available for postpartum depression, or depression after childbirth?
What are the long-term effects of common antidepressant medications, such as SSRIs or SNRIs? Do they cause permanent changes?
First and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review
Treatment for Bipolar Disorder in Adults: A Systematic Review
Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
MedTEAM (Medication Treatment, Evaluation, and Management) Evidence-Based Practices (EBP) Kit
How do I start a clozapine clinic or system, or start to prescribe clozapine?
Are there newer technologies, such as point of care (POC) tests or finger stick blood tests, that can help ease the monitoring burden and facilitate management of clozapine?
How should I transition, taper or discontinue an existing antipsychotic medication when starting clozapine?
What should I do if a patient misses a scheduled dose of, or experiences a gap in their long-acting injectable (LAI) treatment?
How do I establish tolerability before starting a long-acting injectable antipsychotic medication (LAI), and how do I ensure the patient will not have side effects?
What about asymptomatic increases in liver function tests or transaminases while taking psychotropic medication?
Clozapine for Schizophrenia: A Comparison of the States
Canadian Practice Guidelines for Comprehensive Community Treatment for Schizophrenia Spectrum Disorders
Medication Management of Bipolar Disorder During the Reproductive Years
Maintenance Dose Conversion Between Oral Risperidone and Paliperidone Palmitate 1 Month: Practical Guidance Based on Pharmacokinetic Simulations
NAVIGATE Manuals
Clozapine Center of Excellence
Is clozapine more effective than other antipsychotic medications in individuals with treatment-resistant psychosis?
OnTrackNY Team Manuals
Are there concerns regarding urinary retention and antidepressant medications?
What is post-injection delirium sedation syndrome (PDSS) that is associated with the olanzapine long-acting injectable (Zyprexa Relprevv)?
What about prescribing anticholinergic medications such as benztropine to patients taking antipsychotic medications?
When prescribing, what should I consider regarding doses of antipsychotic medications, oral or long-acting injectable medications?
What is known about tinnitus, antidepressant medications, depression, and anxiety?
Is it possible to use fluvoxamine to improve the tolerability or metabolic side effects of clozapine?
Recorded Bipolar Psychopharmacology Consultation Line Webinar
Can clozapine cause Obsessive Compulsive Disorder (OCD), and what can be done about this?
Long-Acting Injectable Center of Excellence
What is known about prescription and use of antipsychotic and other medications during pregnancy, in pregnant women with schizophrenia?
Are there antipsychotic medication handouts for patients?
Are there any concerns with regard to prescribing or using concomitant medications or substances during treatment with ketamine or transcranial magnetic stimulation (TMS)?
Are paliperidone (Invega) and risperidone (Risperdal) similar or different?
What can be done when a patient has depression that is treatment resistant (does not respond fully to antidepressant medication treatment)?
Antidepressants – Medication Fact Sheets (Spanish Version)
Anticonvulsants – Medication Fact Sheets (Spanish Version)
Mood Stabilizers – Medication Fact Sheets (Spanish Version)
First-Generation (typical) Antipsychotics – Medication Fact Sheets (Spanish Version)
Second-Generation (atypical) Antipsychotics – Medication Fact Sheets (Spanish Version)
What can be done if a patient taking clozapine is travelling to a foreign country?
Psychosis and Schizophrenia in Adults: Treatment and Management – Updated Edition 2014
What is known about overlapping or cross-titration of psychiatric medications?
What is known about the causes of restless legs or akathisia?
What is known about lumateperone tosylate (Caplyta) for psychosis or schizophrenia?
What should clinicians who work with American Indian/Alaska Native people consider when prescribing long-acting injectable (LAI) antipsychotics?
What is known about the evaluation and treatment of serious mental illness in older adults?
Can patients with chronic schizophrenia stop taking antipsychotic medications?
Can risperidone, paliperidone (Invega) or first generation antipsychotic medications cause elevated or high prolactin levels, and related side effects such as sexual dysfunction, gynecomastia or galactorrhea?
Clinical use of lithium salts: guide for users and prescribers
Antidepressants in bipolar depression: an enduring controversy
Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy
Should varenicline and nicotine replacement therapy be used together for treatment of nicotine dependence in patients with serious mental illness?
What tobacco cessation products are covered under Medicaid?
What should clinicians know about prescribing (naltrexone) Vivitrol injections for patients with co-occuring alcohol use disorder?
What drug-drug interactions should you be vigilant for when someone is prescribed carbamazepine?
Is there a role for therapeutic drug monitoring when someone is prescribed carbamazepine?
How do you treat delusional disorder?
Atypical Injectable Antipsychotics for Schizophrenia or Bipolar Disorder: A Review of Clinical Effectiveness and Cost-Effectiveness
Is clozapine safe to continue during breastfeeding?
What guidance is there for clinicians who treat older adults with schizophrenia?
Are antidepressants safe for individuals who have bipolar disorder?
Ask About Clozapine – Patient Handout
A Survey of Personnel and Services Offered in 32 Outpatient US Clozapine Clinics
What is tardive dyskinesia (TD)?
What is deprescribing?
Clozapine & LAI Virtual Forum – August 2022 (Video) – LAI Discontinuation
Vigilance and Monitoring for Clozapine Toxicity During COVID-19 Infection and Recommendations for Management
Video: Intramuscular (IM) Injection of Long-acting Injectables into Deltoid Site
Video: Intramuscular (IM) Injection of Long-acting Injectables into Ventral Gluteal (or Ventrogluteal) Site
Video: Intramuscular (IM) Injection of Long-acting Injectables into Dorsal Gluteal (or Dorsogluteal) Site
Video: Subcutaneous (SC) Injection of Long-acting Injectables into Abdominal Site
Clozapine & LAI Virtual Forum – November 2022 (Video) – Management of clozapine-induced constipation
Video: Subcutaneous (SC) Injection of Long-acting Injectables into Lateral Aspect of Upper Arm
Clozapine & LAI Virtual Forum – February 2023 (Video) – Comprehensive Screening for Antipsychotic-Induced Movement Disorders Via Telehealth
Clozapine & LAI Virtual Forum – March 2023 (Video) – Managing Sedation Due to Clozapine
What is a good approach when you inherit an older adult patient from another prescriber on long-term high-dose benzodiazepine prescription that is not a dose with which you are comfortable prescribing?
Clozapine & LAI Virtual Forum – May 2023 (Video) – Management of Clozapine-Induced Sialorrhea: Highlighting Botulinum Toxin
Clozapine & LAI Virtual Forum – June 2023 (Video) – Update on the Long-Acting Injectable Antipsychotic Medications
Clozapine & LAI Virtual Forum – August 2023 (Video) – Non-antipsychotic, pharmacologic augmentation strategies to partial responders on clozapine
Is there only one best titration standard for starting clozapine?
Is clozapine a medication that should only be used when all other medications have failed?
Clozapine & LAI Virtual Forum – September 2023 (Video) – Making Sense of the Long-Acting Injectable (LAI) Antipsychotic Medication Research
Clozapine & LAI Virtual Forum – October 2023 (Video) -Debrief on New Long-acting Injectable Antipsychotic Medications (LAIs)
Clozapine & LAI Virtual Forum – November 2023 (Video) – Demystifying Lithium’s Renal Effects
First-line Treatments for Clozapine-induced Drooling (Videos & Handouts)
Clozapine & LAI Virtual Forum – January 2024 (Video) – Clozapine’s Unique Role for Managing Aggressive Behavior
Myth vs. Fact on Serious Mental Illness (Infographics)
Clozapine & LAI Virtual Forum – February 2024 (Video) – Comparing Aripiprazole LAI Products
Clozapine & LAI Virtual Forum – March 2024 (Video) – Debating the Use of Clozapine with Fluvoxamine
How do I prescribe lithium?
Maximizing Treatment Outcomes with Lithium: A Video Series for Healthcare Professionals
Clozapine & LAI Virtual Forum – June 2024 (Video) – Therapeutic Drug Monitoring (TDM) for Antipsychotic Medications

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Administered by

Funded by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2024 American Psychiatric Association. All rights reserved.